Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change

Frost, Bess, Ollesch, Julian, Wille, Holger, Diamond, Marc I.·2009·Journal of Biological Chemistry

Cited by (224)

Items 101–200 of 224

  1. Chemical Features of Polyanions Modulate Tau Aggregation and Conformational States
    Kelly M. Montgomery, Emma C. Carroll, Aye C. Thwin, Athena Quddus, Paige Hodges, Daniel R. Southworth, Jason E. Gestwicki · 2023 · Journal of the American Chemical Society
  2. The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer’s Disease
    Zizhen Si, Xidi Wang · 2020 · Journal of Alzheimer s Disease
  3. RNA induces unique tau strains and stabilizes Alzheimer’s disease seeds
    Amy N. Zwierzchowski-Zarate, Aydé Mendoza‐Oliva, Omar M. Kashmer, Josue E. Collazo-Lopez, Charles L. White, Marc I. Diamond · 2022 · Journal of Biological Chemistry
  4. Applications of Resting-State Functional Connectivity to Neurodegenerative Disease
    Juan Helen Zhou, Siwei Liu, Kwun Kei Ng, Juan Wang · 2017 · Neuroimaging Clinics of North America
  5. Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
    Meyer, Virginia, Dinkel, Paul D., Luo, Yin, Yu, Xiang, Wei, Guanghong, Zheng, Jie, Eaton, Gareth R., Ma, Buyong, Nussinov, Ruth, Eaton, Sandra S. et al. · 2014 · Angewandte Chemie International Edition
  6. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases
    Bahareh Eftekharzadeh, Bradley T. Hyman, Susanne Wegmann · 2016 · Mechanisms of Ageing and Development
  7. Seed-competent tau monomer initiates pathology in a tauopathy mouse model
    Hilda Mirbaha, Dailu Chen, Vishruth Mullapudi, Sandi Jo Terpack, Charles L. White, Łukasz A. Joachimiak, Marc I. Diamond · 2022 · Journal of Biological Chemistry
  8. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases
    Daniela Sarnataro · 2018 · International Journal of Molecular Sciences
  9. Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
    C.C. Raiss, Theresa Braun, Irene B. M. Konings, Heinrich Grabmayr, Gerco C. Hassink, Arshdeep Sidhu, Joost le Feber, Andreas R. Bausch, Casper Jansen, Vinod Subramaniam et al. · 2016 · Scientific Reports
  10. The expanding realm of prion phenomena in neurodegenerative disease
    Bess E Frost, Marc I. Diamond · 2009 · Prion
  11. F-Actin Binding Regions on the Androgen Receptor and Huntingtin Increase Aggregation and Alter Aggregate Characteristics
    Suzanne Angeli, Jieya Shao, Marc I. Diamond · 2010 · PLoS ONE
  12. Modelling female physiology from head to Toe: impact of sex hormones, menstrual cycle, and pregnancy
    Abo, Stéphanie, Smith, Delaney, Stadt, Melissa, Layton, Anita · 2022 · Journal of Theoretical Biology
  13. Supramolecular Non-Amyloid Intermediates in the Early Stages of α-Synuclein Aggregation
    Jonathan A. Fauerbach, Dmytro A. Yushchenko, Sarah H. Shahmoradian, Wah Chiu, Thomas M. Jovin, Elizabeth Andrea Jares-Erijman · 2012 · Biophysical Journal
  14. Genome-wide association study and functional validation implicates JADE1 in tauopathy
    Kurt W. Farrell, SoongHo Kim, Natalia Han, Megan A. Iida, Elias M. Gonzalez, Marcos Otero‐García, Jamie M. Walker, Timothy E. Richardson, Alan Edward Renton, Shea J. Andrews et al. · 2021 · Acta Neuropathologica
  15. Tauons and Prions: Infamous Cousins?
    Petr Novák, Michal Prčina, Eva Kontseková · 2011 · Journal of Alzheimer s Disease
  16. Human prion diseases: Molecular, cellular and population biology
    Mark W. Head · 2013 · Neuropathology
  17. Secondary Nucleation and the Conservation of Structural Characteristics of Amyloid Fibril Strains
    Saeid Hadi Alijanvand, Alessia Peduzzo, Alexander Kai Buell · 2021 · Frontiers in Molecular Biosciences
  18. Structurally Distinct Polymorphs of Tau Aggregates Revealed by Nanoscale Infrared Spectroscopy
    Siddhartha Banerjee, Ayanjeet Ghosh · 2021 · The Journal of Physical Chemistry Letters
  19. Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils
    Bartosz Niżyński, Hanna Nieznańska, Robert Dec, Solomiia Boyko, Wojciech Dzwolak, Krzysztof Nieznański · 2018 · PLoS ONE
  20. Conformational Evolution of Molecular Signatures during Amyloidogenic Protein Aggregation
    George Devitt, William Rice, Anna Crisford, Iris S. Nandhakumar, Amritpal K. Mudher, Sumeet Mahajan · 2019 · ACS Chemical Neuroscience
  21. Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
    Luciana Medina, Florencia González‐Lizárraga, Antonio Dominguez‐Meijide, Diego Ploper, Valeria Parrales, Sabrina Sequeira, Maria‐Sol Cima‐Omori, Markus Zweckstetter, Elaine Aparecida Del Bel, Patrick Pierre Michel et al. · 2021 · Frontiers in Aging Neuroscience
  22. Cytotoxic tau released from lung microvascular endothelial cells upon infection with Pseudomonas aeruginosa promotes neuronal tauopathy
    Chung‐Sik Choi, Meredith S. Gwin, Sarah B. Voth, Claire Kolb, Chun Zhou, Amy R. Nelson, A. Deweever, Anna Koloteva, Naga S. Annamdevula, James M. Murphy et al. · 2021 · Journal of Biological Chemistry
  23. Cytosolic aggregates perturb the degradation of nontranslocated secretory and membrane proteins
    Oishee Chakrabarti, Neena S. Rane, Ramanujan S. Hegde · 2011 · Molecular Biology of the Cell
  24. Studying the effects of chaperones on amyloid fibril formation.
    Hong Zhang, Li-qiong Xu, S. Perrett · 2011 · Methods
  25. Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation
    Nathalie Daude, Chae Kim, Sang‐Gyun Kang, Ghazaleh Eskandari‐Sedighi, Tracy Haldiman, Jing Yang, Shelaine C. Fleck, Erik Gomez‐Cardona, Zhuang Zhuang Han, Sergi Borrego‐Écija et al. · 2020 · Acta Neuropathologica
  26. Biochemical and strain properties of CJD prions: complexity versus simplicity
    Stéphane Haı̈k, Jean‐Philippe Brandel · 2011 · Journal of Neurochemistry
  27. Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter
    Lidia Glodzik, Amy F. Kuceyeski, Henry Rusinek, Wai-Hon Tsui, Lisa Mosconi, Yi Li, Ricardo S. Osorio, S. Williams, Catherine Randall, Nicole C. Spector et al. · 2014 · NeuroImage
  28. Fracture and Growth Are Competing Forces Determining the Fate of Conformers in Tau Fibril Populations
    Virginia Meyer, Michael R. Holden, Hilary A. Weismiller, Gareth R. Eaton, Sandra S. Eaton, Martin Margittai · 2016 · Journal of Biological Chemistry
  29. The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain
    Rosalina Gavı́n, Laia Lidón, Isidró Ferrer, José Antonio del Rı́o · 2020 · Cells
  30. Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
    Natalia Fernández‐Borges, Hasier Eraña, Saioa R. Elezgarai, Chafik Harrathi, Mayela Gayosso, Joaquı́n Castilla · 2013 · International Journal of Cell Biology
  31. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins
    Hasier Eraña, Vanesa Venegas, Jorge M. Charco, Joaquı́n Castilla · 2016 · Biochemical and Biophysical Research Communications
  32. Mechanistic and Structural Origins of the Asymmetric Barrier to Prion-like Cross-Seeding between Tau-3R and Tau-4R
    Harish Kumar, Jayant B. Udgaonkar · 2018 · Journal of Molecular Biology
  33. Liquid Droplet Aging and Seeded Fibril Formation of the Cytotoxic Granule Associated RNA Binding Protein TIA1 Low Complexity Domain
    Yuuki Wittmer, Khaled M. Jami, Rachelle K. Stowell, Truc Le, Ivan Hung, Dylan T. Murray · 2023 · Journal of the American Chemical Society
  34. Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01
    Aida Attar, Farid Rahimi, Gal Bitan · 2013 · Translational Neuroscience
  35. Nanobiotechnology in Neurodegenerative Diseases
    Josef Jampílek, Katarína Kráľová, Petr Novák, Michal Novák · 2019 · Springer eBooks
  36. Intraneuronal tau aggregation induces the integrated stress response in astrocytes
    Kevin Llewelyn Batenburg, Nael Nadif Kasri, Vivi Majella Heine, Wiep Scheper · 2022 · Journal of Molecular Cell Biology
  37. The Brain’s Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer’s Disease
    Sneha Pandya, Alzheimer’s Disease Neuroimaging Initiative, Amy F. Kuceyeski, Ashish Raj · 2016 · Journal of Alzheimer s Disease
  38. Detection and Characterization of Small Molecule Interactions with Fibrillar Protein Aggregates Using Microscale Thermophoresis
    Emily Fisher, Yanyan Zhao, Robert Richardson, Malgorzata Aneta Janik, Alexander Kai Buell, Franklin I. Aigbirhio, Gergely Tóth · 2017 · ACS Chemical Neuroscience
  39. Graph Models of Pathology Spread in Alzheimer's Disease: An Alternative to Conventional Graph Theoretic Analysis
    Ashish Raj · 2021 · Brain Connectivity
  40. Cellular Models for the Study of Prions
    Brandon B. Holmes, Marc I. Diamond · 2016 · Cold Spring Harbor Perspectives in Medicine
  41. Cortical morphometry and neural dysfunction in Huntington’s disease: a review
    Brendan Tan, Rosita Shishegar, Govinda Raj Poudel, Alex Fornito, Nellie Georgiou‐Karistianis · 2020 · European Journal of Neurology
  42. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies
    Niccolò Candelise, Matthias Schmitz, Susana Correia, Amandeep Singh Arora, Anna Villar‐Piqué, Saima Zafar, Franc Llorens, Maria Cramm, Inga Zerr · 2017 · Expert Review of Molecular Diagnostics
  43. Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies
    Akemi Ido, Hidenao Fukuyama, Makoto Urushitani · 2011 · International Journal of Molecular Sciences
  44. Synaptic oligomeric tau in Alzheimer’s disease – a potential culprit in the spread of tau pathology through the brain
    Martí Colom‐Cadena, Caitlin Davies, Sònia Sirisi, Ji-Eun Lee, Elizabeth M. Simzer, Makis Tzioras, Marta Querol‐Vilaseca, Érika Sánchez‐Aced, Ya Yin Chang, Kristján Holt et al. · 2023 · medRxiv
  45. Altered functional connectivity of cortical networks in semantic variant primary progressive aphasia
    Popal, Haroon, Quimby, Megan, Hochberg, Daisy, Dickerson, Bradford C., Collins, Jessica A. · 2020 · NeuroImage: Clinical
  46. Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer’s cases
    Tarun V. Kamath, Naomi Klickstein, Caitlin Commins, Analiese R. Fernandes, Derek H. Oakley, Matthew P. Frosch, Bradley T. Hyman, Simon Dujardin · 2021 · Brain Communications
  47. Amyotrophic lateral sclerosis and organ donation: Is there risk of disease transmission?
    Brandon B. Holmes, Marc I. Diamond · 2012 · Annals of Neurology
  48. Tau in the gut, does it really matter?
    Pascal Derkinderen, Malvyne Rolli‐Derkinderen, Guillaume Chapelet, Michel Neunlist, Wendy J. Noble · 2021 · Journal of Neurochemistry
  49. Neurogenetic traits outline vulnerability to cortical disruption in Parkinson’s disease
    Silvia Basaia, Federica Agosta, Ibai Palacio Diez, Elisenda Bueichekú, Federico d’Oleire Uquillas, Manuel Delgado‐Alvarado, César Caballero‐Gaudes, MariCruz Rodriguez-Oroz, Tanja Stojković, Vladimir Kostić et al. · 2022 · NeuroImage Clinical
  50. 4,4-Difluoroproline as a Unique 19 F NMR Probe of Proline Conformation
    Himal Kanti Ganguly, Brice A. Ludwig, Caitlin M. Tressler, Megh R. Bhatt, Anil K. Pandey, Caitlin M. Quinn, Shi Bai, Glenn P. A. Yap, Neal Joseph Zondlo · 2024 · Biochemistry
  51. Conformation-based assay of tau protein aggregation
    Yann Fichou, Neil A. Eschmann, Timothy J. Keller, Songi Han · 2017 · Methods in cell biology
  52. Trans‐seeding of Alzheimer‐related tau protein by a yeast prion
    Martin Flach, Cedric Leu, Alfonso Martinisi, Zhiva Kalinova Skachokova, Stephan Frank, Markus Tolnay, Henning Stahlberg, David T. Winkler · 2022 · Alzheimer s & Dementia
  53. Cupric Ions Induce the Oxidation and Trigger the Aggregation of Human Superoxide Dismutase 1
    Cheng Li, Wen-Chang Xu, Zhensheng Xie, Kai Pan, Jiao Hu, Jie Chen, Dai‐Wen Pang, Fu-Quan Yang, Yi Liang · 2013 · PLoS ONE
  54. Advanced imaging of tau pathology in Alzheimer Disease: New perspectives from super resolution microscopy and label‐free nanoscopy
    Gabriele S. Kaminski Schierle, Claire H. Michel, Laura Gasparini · 2016 · Microscopy Research and Technique
  55. Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species
    Verian Bader, Philipp Ottis, Martin E. Pum, Joseph P. Huston, Carsten Korth · 2012 · Journal of Visualized Experiments
  56. Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
    Harish Kumar, Jayant B. Udgaonkar · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  57. Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools
    Isabelle Landrieu, Elian Dupré, Davy Sinnaeve, Léa El Hajjar, Caroline Smet‐Nocca · 2022 · Frontiers in Chemistry
  58. Connectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
    Justin Torok, Chaitali Anand, Parul Verma, Ashish Raj · 2022 · Translational research
  59. Tau seeding without tauopathy
    Michael LaCroix, Efrosini Artikis, Brian D. Hitt, Joshua D. Beaver, Sandi Jo Estill, Kelly Gleason, Carol A. Tamminga, Bret M. Evers, Charles L. White, Byron W. Caughey et al. · 2023 · Journal of Biological Chemistry
  60. Investigating Fibrillar Aggregates of Tau Protein by Atomic Force Microscopy
    Susanne Wegmann, Daniel J. Müller, Eckhard Mandelkow� · 2012 · Methods in molecular biology
  61. Comparison of the molecular properties of retinitis pigmentosa P23H and N15S amino acid replacements in rhodopsin
    James Mitchell, Fernanda Balem, Kalyan C. Tirupula, David Man, Harpreet Kaur Dhiman, Naveena V. K. Yanamala, Julian Ollesch, Joan Planas-Iglesias, Barbara Jennings, Klaus Bernhard Gerwert et al. · 2019 · PLoS ONE
  62. Structural and functional connectivity in tau mutation carriers: from presymptomatic to symptomatic frontotemporal dementia
    Arabella Bouzigues, Vincent Le Du, Matthieu Joulot, Ninon Peysson, Marion Houot, Benoît Béranger, Lucy Louise Russell, Phoebe H. Foster, Eve Ferry‐Bolder, John Cornelis Van Swieten et al. · 2025 · Alzheimer s & Dementia
  63. Strains of Pathological Protein Aggregates in Neurodegenerative Diseases
    Xinzhu Wang, Zeinab Noroozian, Madelaine Lynch, Nicholas Armstrong, Raphaël Schneider, Mingzhe Liu, Farinaz Ghodrati, Ashley B. Zhang, Yoo Jeong Yang, Amanda C. Hall et al. · 2017 · Discoveries
  64. Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates
    Tohidul Islam, Hlin Kvartsberg, Anuradha Sehrawat, Przemysław Radosław Kac, Bruno Becker, Maria Olsson, Eric E. Abrahamson, Henrik Zetterberg, Miloš D. Ikonomović, Kaj Blennow et al. · 2024 · Alzheimer s & Dementia
  65. Alzheimer's disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models
    Sourav Kolay, Marc I. Diamond · 2020 · FEBS Open Bio
  66. β-Bracelets: Macrocyclic Cross-β Epitope Mimics Based on a Tau Conformational Strain
    Benjamin H. Rajewski, Kamlesh Madhusudan Makwana, Isaac J. Angera, Danielle K. Geremia, Anna R. Zepeda, Grace I. Hallinan, Rubén Vidal, Bernardino Francesco Ghetti, Arnaldo L. Serrano, Juan R. Del Valle · 2023 · Journal of the American Chemical Society
  67. Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation
    Kerry T. Sun, Tark Patel, Sang‐Gyun Kang, Allan Yarahmady, Mahalashmi Srinivasan, Olivier Julien, Jónathan Heras, Sue‐Ann Mok · 2023 · ACS Chemical Neuroscience
  68. Editorial: Network Spread Models of Neurodegenerative Diseases
    Ashish Raj, Yasser Iturria‐Medina · 2019 · Frontiers in Neurology
  69. Inhibition of tau aggregation by the CCT3 and CCT7 apical domains
    Miki Ben‐Maimon, Nadav Elad, Segev Naveh‐Tassa, Yaakov Levy, Amnon Horovitz · 2025 · Protein Science
  70. Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
    Virginia Meyer, Paul D. Dinkel, Yin Luo, Xiang Yu, Guanghong Wei, Jie Zheng, Gareth R. Eaton, Buyong Ma, Ruth Nussinov, Sandra S. Eaton et al. · 2014 · Angewandte Chemie
  71. TauLUM, an in vivo Drosophila sensor of tau multimerization, identifies neuroprotective interventions in tauopathy
    Simon A. Levy, Gabrielle Zuniga, Elias M. Gonzalez, David Butler, Sally Temple, Bess E Frost · 2022 · Cell Reports Methods
  72. Prion Protein Aggregation and FibrillogenesisIn Vitro
    Jan Stöhr · 2012 · Sub-cellular biochemistry/Subcellular biochemistry
  73. Inert and seed-competent tau monomers suggest structural origins of aggregation
    Hilda Mirbaha, Dailu Chen, Olga A. Morozova, Kiersten M. Ruff, Apurwa Sharma, Xiaohua Liu, Rohit V. Pappu, David W. Colby, Hamid Mirzaei, Łukasz A. Joachimiak et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Making tau amyloid models in vitro: a crucial and underestimated challenge
    Julien Broc, Clara Piersson, Yann Fichou · 2025 · FEBS Letters
  75. Alzheimer Research Series on the Default Network
    Pat McCaffrey, Tom Fagan, Esther Wei-Yun Landhuis · 2010 · Journal of Alzheimer s Disease
  76. Serine-404 Phosphorylation and the R406W Modification in Tau Stabilize the cis-Proline Amide Bond, via Phosphoserine-Proline C–H/O and Proline-Aromatic C–H/π Interactions
    Himal Kanti Ganguly, Michael B. Elbaum, Neal Joseph Zondlo · 2023 · ChemRxiv
  77. Targeted tau protein degradation: a promising therapeutic approach for tauopathies
    Narjes Baazaoui, Mohammad Yahya Alfaifi, Ali Abdullah Shati, Rania Ben Saad, Stefanıa Garzoli · 2025 · Neuroscience
  78. Illuminating the Structural Basis of Tau Aggregation by Intramolecular Distance Tracking: A Perspective on Methods
    Zhikai Zeng, Yann Fichou, Michael P. Vigers, Karen Tsay, Songi Han · 2022 · The Journal of Physical Chemistry B
  79. Brain Network Functional Connectivity in Alzheimer’s Disease and Frontotemporal Dementia
    Juan Helen Zhou, Kwun Kei Ng, Siwei Liu · 2020 · Springer eBooks
  80. Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species
    Verian Bader, Philipp Ottis, Martin E. Pum, Joseph P. Huston, Carsten Korth · 2012 · Journal of Visualized Experiments
  81. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease
    Marcella Catania, Giuseppe Di Fede · 2020 · Progress in molecular biology and translational science
  82. Passaging Human Tauopathy Patient Samples in Cells Generates Heterogeneous Fibrils with a Subpopulation Adopting Disease Folds
    Zhikai Zeng, Karen Tsay, Vishnu Vijayan, Matthew P. Frost, Shikhar Prakash, Athena Quddus, Alexa Albert, Michael P. Vigers, Madhur Srivastava, Amanda L. Woerman et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  83. In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils
    Hope Pan, Xinyi Cheng, Jeffrey Zhang, Ke Hou, Kevin A. Murray, Kapil Manglani, Cansheng Zhu, Hung‐Kai Hsu, Marisa Mekkittikul, Tyler Halladay et al. · 2026 · ACS Chemical Neuroscience
  84. Impact of Sterilization Methods on the Seeding Ability of Human Tau Proteopathic Seeds
    Analiese R. Fernandes, Simon Dujardin, Anastasie Maté de Gérando, Bradley T. Hyman, Matthew P. Frosch · 2021 · Journal of Neuropathology & Experimental Neurology
  85. Probing the Interactions of LRP1 Ectodomain-Derived Peptides with Fibrillar Tau Protein and Its Impact on Cellular Internalization
    E. Josephine Boder, Beatriz G. Goncalves, Charlotta G. Lebedenko, Ipsita A. Banerjee · 2023 · Applied Sciences
  86. Prion-Like Propagation in Neurodegenerative Diseases
    Wouter Peelaerts, Veerle Baekelandt, Patrik Brundin · 2018 · Elsevier eBooks
  87. Connectome-Mediated Prediction of Future Tau-PET Burden in Alzheimer’s Disease
    Pablo F. Damasceno, Renaud La Joie, Sergey Shcherbinin, Sudeepti S. Southekal, Vikas Kotari, Ixavier A. Higgins, Emily C. Collins, Gil D. Rabinovici, Mark A Mintun, Ashish Raj · 2022 · Journal of Biotechnology and Biomedicine
  88. Seed-competent tau monomer initiates pathology in PS19 tauopathy mice
    Hilda Mirbaha, Dailu Chen, Vishruth Mullapudi, Sandi Jo Terpack, Charles L. White, Łukasz A. Joachimiak, Marc I. Diamond · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Central and peripheral tau retention modulated by an anti-tau antibody
    Alexander G. Solorzano, Molly Brady, Nemil N. Bhatt, Angelique Johnson, Brooke Burgess, Hannah Leyva, Nicha Puangmalai, Cynthia Jerez, Ronald W. Wood, Rakez Kayed et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  90. The Prion-Like Aspect of Alzheimer Pathology
    Sarah K. Fritschi, Bahareh Eftekharzadeh, Giusi Manfredi, Tsuyoshi Hamaguchi, Götz Heilbronner, Amudha Nagarathinam, Franziska Langer, Yvonne S. Eisele, Lary C. Walker, Mathias Jucker · 2013 · Research and perspectives in Alzheimer's disease
  91. The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
    Laura Morelli, George L. Perry, Fabrizio Tagliavini · 2012 · International Journal of Alzheimer s Disease
  92. Keystone Symposium, Neurodegenerative Diseases: New Molecular Mechanisms 17–22 February 2009
    Tom Fagan · 2009 · Journal of Alzheimer s Disease
  93. Tau local structure shields amyloid motif and controls aggregation propensity
    Dailu Chen, Kenneth W. Drombosky, Zhiqiang Hou, Levent Sari, Omar M. Kashmer, Bryan D. Ryder, Valerie A. Perez, DaNae R. Woodard, Milo M. Lin, Marc I. Diamond et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Exploring the Biological Connection Between Tau and PrPC in Neuronal Cells: GSK3β as a Possible Key Player
    Rosalina Gavín, José Antonio del Río · 2025 · Molecular Neurobiology
  95. Polymorphism of Tau Fibrils
    Yoshiaki Furukawa · 2013 · Elsevier eBooks
  96. Prion-Like Properties of Assembled Tau Protein
    Florence Clavaguera, Markus Tolnay, Michel Goedert · 2013 · Research and perspectives in Alzheimer's disease
  97. Experimental Models of Tau Aggregation
    Kerstin Buck, Thomas Robert Jahn, Laura Gasparini · 2018 · Elsevier eBooks
  98. Tau Aggregation, Conformational Selection, and Inhibition
    Michael R. Holden · 2018 · Digital Commons - DU (University of Denver)
  99. Doxycycline interferes with tau amyloid aggregation abolishing its associated neuronal toxicity
    Luciana Medina, Florencia González‐Lizárraga, Antonio Dominguez‐Meijide, Diego Ploper, Valeria Parrales, Sabrina Sequeira, Maria Sol Cima-Omori, Markus Zweckstetter, Elaine Del Bel, Patrick Pierre Michel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Network Models of Dementia Progression: the Way Forward?
    Ashish Raj · 2012 · Future Neurology